| Hans-Günter Meyer-Thompson | Hepatitiden
Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial.
Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial.
Lim, AG, Aas, CF, Çağlar, ES, Vold, JH, Fadnes, LT, Vickerman, P, et al. Addiction. 2023. doi.org/10.1111/add.16305